Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Appointed CFO
Quarterly results
Appointed director
CC transcript

ALEXION PHARMACEUTICALS, INC. (ALXN) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/13/2021 GN STOCK ALERT: Halper Sadeh LLP Investigates MGLN, CATM, EGOV, ALXN; Shareholders Are Encouraged to Contact the Firm
01/01/2021 GN MERGER INVESTIGATION ALERT: Halper Sadeh LLP Encourages RP, MDCA, ALXN, SPWH Shareholders to Contact the Firm
12/15/2020 GN ALEXION ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of ALXN and Encourages Investors to Contact the Firm
12/15/2020 GN SHAREHOLDER ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Investors are Encouraged to Contact the Firm – ALXN, PS, HBAN, CKH
12/14/2020 GN SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Alexion Pharmaceuticals, Inc. Buyout
12/19/2019 GN Achillion Shareholders Approve Agreement to be Acquired by Alexion
10/29/2019 GN SHAREHOLDER ALERT: WeissLaw LLP Reminds HLND, TNCB, ACHN, RARX Shareholders About Its Ongoing Investigations
03/06/2019 GN Analysis: Positioning to Benefit within Bristol-Myers Squibb, AAR, Central Garden & Pet, Alexion Pharmaceuticals, Tribune Media, and Civitas Solutions — Research Highlights Growth, Revenue, and Consolidated Results
08/08/2018 GN Recent Analysis Shows Washington Real Estate Investment Trust, FirstEnergy, Alexion Pharmaceuticals, Alaska Air Group, Fortune Brands Home & Security, and Baxter International Market Influences — Renewed Outlook, Key Drivers of Growth
12/06/2017 GN Factors of Influence in 2018, Key Indicators and Opportunity within Intuit, Alexion Pharmaceuticals, Salesforce, Jack In The Box, MedEquities Realty Trust, and Fiesta Restaurant Group — New Research Emphasizes Economic Growth
03/16/2017 GN Arbutus Licenses LNP Delivery Technology to Alexion for Use in Single Messenger RNA Product Candidate

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy